ResMed, Inc. (RMD) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $219.58 -0.17%
Revenue Growth %: +6.9%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +6.9%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $349.1 million versus the consensus estimate of $339.56 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Cosciens acquires Nualtis for up to $15M in cash deal
- Adobe beats Q3 targets, but soft Q4 sales guidance triggers dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
